课题基金 / 基金详情

JHU Center for the Advancement of HIV Neurotherapeutics (JHU CAHN) - Biomarker Core

JHU Center for the Advancement of HIV Neurotherapeutics (JHU CAHN) - Biomarker Core
JHU Center for the Advancement of HIV Neurotherapy (JHU CAHN) - 生物标志物核心
批准号:
10584555
负责人:
Rebecca Terilli Veenhuis
金额:
$27.26万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2006
资助国家:
美国
项目状态:
未结题
起止时间:
2006-06-16 至 2027-02-28

项目摘要

项目成果

Rebecca Terilli Veenhuis的其他基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
PROJECT SUMMARY - BIOMARKER CORE The JHU Center for the Advancement of HIV Neurotherapeutics (JHU CAHN) will focus on a CNS complications that commonly present in PWH based on the framework of the NIMH Research Domain Criteria (RDoC) that classifies CNS complications based on dimensions of observable behavior and neurobiological measures that include Negative and Positive Valence Systems (e.g., anhedonia, fear), Sensorimotor Systems, Systems for Social Processes (e.g., social avoidance), Arousal/Regulatory Systems (e.g., sleep), and cognition. This framework provides new opportunities to more accurately associate biomarkers with particular symptomology with the goal of identifying molecular targets for the development of personalized medicine approaches by the Therapeutics and Clinical Cores. The Biomarker Core will work closely with the Therapeutic and Clinical cores to integrate multi-dimensional data and tools such as machine learning algorithms and offer these services to investigators interested in NeuroHIV. Technical services will include mass spectrometry analysis for metabolites, lipids, and proteins, multiplex Meso Scale discovery assays, extracellular vesicle isolation and cargo characterization. Informatics analyses offered will include Small Molecules Pathway Database, Kyoto Encyclopedia of Genes and Genomes, Cytoscape, and Ingenuity Pathway Analysis. Advanced non-parametric analyses will include a variety of multivariate modeling such as principal component analysis (PCA), partial least squares-discriminant analysis (PLS-DA), and sparse PLS-DA analysis, Significance analysis of metabolites (SAM), and Empirical Bayesian analysis of metabolites (EBAM) models to identify features that discriminate clinical biotypes or experimental groups. These services will be communicated broadly to the NeuroHIV community through our multicenter weekly seminar series. These services are unique to the JHU CAHN, and provide a valuable resource to NeuroHIV investigators at all stages of career development.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Defining sex-based differences in the replication-competent myeloid reservoir in virally suppressed people with HIV and SIV-infected ART-suppressed macaques
  • 批准号:
    10326649
  • 项目类别:
  • 资助金额:
    $80.73万
  • 财政年份:
    2021
  • 负责人:
    Rebecca Terilli Veenhuis
  • 依托单位:
Defining sex-based differences in the replication-competent myeloid reservoir in virally suppressed people with HIV and SIV-infected ART-suppressed macaques
  • 批准号:
    10448236
  • 项目类别:
  • 资助金额:
    $72.39万
  • 财政年份:
    2021
  • 负责人:
    Rebecca Terilli Veenhuis
  • 依托单位:
Defining sex-based differences in the replication-competent myeloid reservoir in virally suppressed people with HIV and SIV-infected ART-suppressed macaques
  • 批准号:
    10627964
  • 项目类别:
  • 资助金额:
    $71.49万
  • 财政年份:
    2021
  • 负责人:
    Rebecca Terilli Veenhuis
  • 依托单位: